All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cervix Cytology

Cervical cytology turned into the standard screening test for cervical malignancy and premalignant cervical sores with the presentation of the Papanicolaou (Pap) smear in 1941 [1]. Fluid based, flimsy layer readiness of cervical cytology examples was a resulting alteration in strategy. Wording for revealing cervical cytology was normalized by the Bethesda System in 1988 [2]. This framework has been reconsidered a few times, and the current framework was created in 2014 (table 1) [3-6]. Human papillomavirus (HPV) testing has now been fused into cervical malignant growth screening. (See "Screening for cervical malignant growth" and "Cervical disease screening tests: Techniques for cervical cytology and human papillomavirus testing".) The cervical cytology report is introduced in a standard organization. Translation of cervical cytology results will be evaluated here. The 2019 American Society of Colposcopy and Cervical Pathology (ASCCP) Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors were discharged in April 2020 [7,8]. This subject is experiencing amendment dependent on these rules and will be accessible in no time. Cervical malignancy screening systems and methods, just as the follow-up of irregular cytology results and treatment of cervical intraepithelial neoplasia (CIN), are explored independently:

High Impact List of Articles

Relevant Topics in Chemistry